Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Feagan

Showing results (361-370 of 464) with videos related to

Pageof 47
Sort By:
Gastroenterology|July 24, 2019
Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's DiseasePieter Hindryckx, Vipul Jairath, Guangyong Zou, et al.
The New England Journal of Medicine|May 4, 2017
Tofacitinib as Induction and Maintenance Therapy for Ulcerative ColitisWilliam J Sandborn, Chinyu Su, Bruce E Sands, et al.
Lancet (London, England)|September 7, 2015
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trialReena Khanna, Brian Bressler, Barrett G Levesque, et al.
Inflammatory Bowel Diseases|September 19, 2025
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's DiseaseStefan Schreiber, Scott D Lee, C Janneke van der Woude, et al.
Inflammatory Bowel Diseases|October 24, 2019
Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's DiseaseJames D Lewis, Paul Rutgeerts, Brian G Feagan, et al.
Journal of Crohn'S & Colitis|September 30, 2016
Long-term Efficacy of Vedolizumab for Ulcerative ColitisEdward V Loftus, Jean-Frédéric Colombel, Brian G Feagan, et al.
The American Journal of Gastroenterology|January 11, 2017
Responsiveness of Endoscopic Indices of Disease Activity for Crohn's DiseaseReena Khanna, GuangYong Zou, Larry Stitt, et al.
The American Journal of Gastroenterology|April 19, 2017
Corrigendum: Responsiveness of Endoscopic Indices of Disease Activity for Crohn's DiseaseReena Khanna, GuangYong Zou, Larry Stitt, et al.
The New England Journal of Medicine|October 19, 2012
Ustekinumab induction and maintenance therapy in refractory Crohn's diseaseWilliam J Sandborn, Christopher Gasink, Long-Long Gao, et al.
Lancet (London, England)|December 20, 2024
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studiesDavid T Rubin, Jessica R Allegretti, Julián Panés, et al.
Pageof 47

Showing results (361-370 of 464) with videos related to

Sort By:
Pageof 47
Gastroenterology|July 24, 2019
Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's DiseasePieter Hindryckx, Vipul Jairath, Guangyong Zou, et al.
The New England Journal of Medicine|May 4, 2017
Tofacitinib as Induction and Maintenance Therapy for Ulcerative ColitisWilliam J Sandborn, Chinyu Su, Bruce E Sands, et al.
Lancet (London, England)|September 7, 2015
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trialReena Khanna, Brian Bressler, Barrett G Levesque, et al.
Inflammatory Bowel Diseases|September 19, 2025
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's DiseaseStefan Schreiber, Scott D Lee, C Janneke van der Woude, et al.
Inflammatory Bowel Diseases|October 24, 2019
Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's DiseaseJames D Lewis, Paul Rutgeerts, Brian G Feagan, et al.
Journal of Crohn'S & Colitis|September 30, 2016
Long-term Efficacy of Vedolizumab for Ulcerative ColitisEdward V Loftus, Jean-Frédéric Colombel, Brian G Feagan, et al.
The American Journal of Gastroenterology|January 11, 2017
Responsiveness of Endoscopic Indices of Disease Activity for Crohn's DiseaseReena Khanna, GuangYong Zou, Larry Stitt, et al.
The American Journal of Gastroenterology|April 19, 2017
Corrigendum: Responsiveness of Endoscopic Indices of Disease Activity for Crohn's DiseaseReena Khanna, GuangYong Zou, Larry Stitt, et al.
The New England Journal of Medicine|October 19, 2012
Ustekinumab induction and maintenance therapy in refractory Crohn's diseaseWilliam J Sandborn, Christopher Gasink, Long-Long Gao, et al.
Lancet (London, England)|December 20, 2024
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studiesDavid T Rubin, Jessica R Allegretti, Julián Panés, et al.
Pageof 47